PacBio and Twist Bioscience Deliver Initial Portfolio of Target Enrichment Panels for HiFi Sequencing
MENLO PARK, Calif. and SOUTH SAN FRANCISCO, Oct. 19, 2022 /PRNewswire/ -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, and Twist Bioscience Corporation, a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced the availability of an initial portfolio of off-the-shelf long-read gene panels. These fixed Twist Alliance panels are designed to capture target regions in a cost-effective and high throughput manner. Customers will also have the ability to develop a fully customizable and scalable panel of their own design for sequencing with PacBio HiFi reads.
- These fixed Twist Alliance panels are designed to capture target regions in a cost-effective and high throughput manner.
- "While these are long-read panels, Twist Alliance panels are developed in partnership with experts in their field to further research and can be made to be compatible with any sequencing technology."
- PacBio and Twist collaborated with researchers at leading institutions to develop two Alliance panels.
- Well designed, custom target enrichment panels enable increased sequencing depth on target genes while reducing overall sequencing.